← Leaderboards
Hexin Chen
University Of South Carolina At Columbia
$2,168,038
Attributed
$3,964,068
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $609.3K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,964,068 · 3
By mechanism
R01$3,566,971 · 2
R21$397,097 · 1
Top collaborators
- Eugenia V Broude4 shared
- Igor B Roninson3 shared
- Peisheng Xu2 shared
- Mengqian Chen1 shared
Most similar at University Of South Carolina At Columbia
Same institution · by research overlap
- Eugenia V Broude$2,038,170
- Peisheng Xu$5,773,962
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMouse ModelPathway InteractionsIn VitroDrug ResistanceCellsTumorResistancePharmaceutical PreparationsMalignant Breast NeoplasmErbb2 GeneTumor GrowthNovel TherapeuticsNeoplasm MetastasisNeoplastic CellPhosphotransferasesMouse Mammary Tumor VirusPropertyKinase InhibitorImmuneCancer Stem CellGene ExpressionDrug TargetingGenomics
Grant awards (10)
Preventing adaptive drug resistance through Mediator kinase inhibition$609,336
R01 · FY2025 · CA
Preventing adaptive drug resistance through Mediator kinase inhibition$582,679
R01 · FY2024 · CA
Preventing adaptive drug resistance through Mediator kinase inhibition$596,858
R01 · FY2023 · CA
Preventing adaptive drug resistance through Mediator kinase inhibition$607,349
R01 · FY2022 · CA
Nanoparticle delivered miR-489 rejuvenates anthracycline-based chemotherapy$217,080
R21 · FY2021 · CA · contact PI
Nanoparticle delivered miR-489 rejuvenates anthracycline-based chemotherapy$180,017
R21 · FY2020 · CA · contact PI
HER2 and the link between inflammation and cancer stem cells$294,899
R01 · FY2016 · CA · contact PI
HER2 and the link between inflammation and cancer stem cells$294,899
R01 · FY2015 · CA · contact PI
HER2 and the link between inflammation and cancer stem cells$286,052
R01 · FY2014 · CA · contact PI
HER2 and the link between inflammation and cancer stem cells$294,899
R01 · FY2013 · CA · contact PI